IL238605A - Converted pyrimidine compounds with alkylamide for use in modulation il-23, il-12, and / or ifnα - Google Patents
Converted pyrimidine compounds with alkylamide for use in modulation il-23, il-12, and / or ifnαInfo
- Publication number
- IL238605A IL238605A IL238605A IL23860515A IL238605A IL 238605 A IL238605 A IL 238605A IL 238605 A IL238605 A IL 238605A IL 23860515 A IL23860515 A IL 23860515A IL 238605 A IL238605 A IL 238605A
- Authority
- IL
- Israel
- Prior art keywords
- ifnα
- alkylamide
- modulation
- compounds useful
- pyrimidine compounds
- Prior art date
Links
- 150000003230 pyrimidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261723827P | 2012-11-08 | 2012-11-08 | |
| PCT/US2013/068866 WO2014074670A1 (en) | 2012-11-08 | 2013-11-07 | ALKYL AMIDE-SUBSTITUTED PYRIMIDINE COMPOUNDS USEFUL IN THE MODULATION OF IL-12, IL-23 AND/OR IFNα |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL238605A0 IL238605A0 (en) | 2015-06-30 |
| IL238605A true IL238605A (en) | 2017-05-29 |
Family
ID=49667570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL238605A IL238605A (en) | 2012-11-08 | 2015-05-04 | Converted pyrimidine compounds with alkylamide for use in modulation il-23, il-12, and / or ifnα |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9540333B2 (enExample) |
| EP (1) | EP2917186B1 (enExample) |
| JP (1) | JP6266639B2 (enExample) |
| KR (1) | KR102205914B1 (enExample) |
| CN (1) | CN104903301B (enExample) |
| AU (1) | AU2013341195B2 (enExample) |
| BR (1) | BR112015009798A2 (enExample) |
| CA (1) | CA2890935A1 (enExample) |
| EA (1) | EA028052B1 (enExample) |
| ES (1) | ES2648226T3 (enExample) |
| IL (1) | IL238605A (enExample) |
| MX (1) | MX2015005561A (enExample) |
| SG (1) | SG11201503395TA (enExample) |
| WO (1) | WO2014074670A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY35126A (es) | 2012-11-08 | 2014-05-30 | Bristol Myers Squibb Co | Ojo es alfa |
| AR094537A1 (es) | 2013-11-07 | 2015-08-12 | Bristol Myers Squibb Co | COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa |
| CN105992768B (zh) | 2013-12-10 | 2018-04-20 | 百时美施贵宝公司 | 用作IL‑12、IL‑23和/或IFNα响应的调节剂的咪唑并哒嗪化合物 |
| EP3532473B1 (en) * | 2016-10-28 | 2021-09-29 | Bristol-Myers Squibb Company | Heterobicyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responses |
| JOP20180011A1 (ar) | 2017-02-16 | 2019-01-30 | Gilead Sciences Inc | مشتقات بيرولو [1، 2-b]بيريدازين |
| CN107857754B (zh) * | 2018-01-15 | 2018-11-09 | 泰山医学院 | 一种化合物及其在制备预防/治疗类风湿性关节炎药物中的应用 |
| AR117398A1 (es) | 2018-03-12 | 2021-08-04 | Abbvie Inc | Inhibidores de la señalización mediada por tirosina cinasa 2 |
| TWI898556B (zh) | 2018-07-13 | 2025-09-21 | 美商基利科學股份有限公司 | 吡咯并[1,2-b]嗒衍生物 |
| MX2021013317A (es) * | 2019-04-30 | 2022-01-18 | Celgene Corp | Terapias de combinacion que comprenden inhibidores de apremilast y tyk2. |
| EP3944859A1 (en) | 2020-07-30 | 2022-02-02 | Assistance Publique Hôpitaux de Paris | Method for treating immune toxicities induced by immune checkpoint inhibitors |
| WO2022175752A1 (en) | 2021-02-19 | 2022-08-25 | Sudo Biosciences Limited | Tyk2 inhibitors and uses thereof |
| AU2022222470A1 (en) | 2021-02-19 | 2023-09-21 | Sudo Biosciences Limited | Tyk2 inhibitors and uses thereof |
| CN119013277A (zh) | 2021-10-25 | 2024-11-22 | 凯麦拉医疗公司 | Tyk2降解剂和其用途 |
| WO2024257023A1 (en) | 2023-06-14 | 2024-12-19 | Alembic Pharmaceuticals Limited | Tyk2 pseudokinase ligands and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9828511D0 (en) * | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
| ATE530530T1 (de) * | 2002-06-28 | 2011-11-15 | Astellas Pharma Inc | Diaminopyrimidincarbonsäureamidderivat |
| KR20050019797A (ko) * | 2002-06-28 | 2005-03-03 | 야마노우치세이야쿠 가부시키가이샤 | 디아미노피리미딘카르복사미드 유도체 |
| ES2380631T3 (es) * | 2004-09-30 | 2012-05-17 | Tibotec Pharmaceuticals | Pirimidinas sustituidas en posición 5 inhibidoras de VIH |
| EP1814878B1 (en) * | 2004-11-24 | 2012-01-04 | Rigel Pharmaceuticals, Inc. | Spiro-2, 4-pyrimidinediamine compounds and their uses |
| AU2007233737B2 (en) * | 2006-03-30 | 2012-11-29 | Janssen Sciences Ireland Uc | HIV inhibiting 5-amido substituted pyrimidines |
| EP2046759A1 (en) * | 2006-07-21 | 2009-04-15 | Novartis AG | 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| WO2009145856A1 (en) * | 2008-04-16 | 2009-12-03 | Portola Pharmaceuticals, Inc. | 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| KR101773313B1 (ko) * | 2008-04-16 | 2017-08-31 | 포톨라 파마슈티컬스, 인코포레이티드 | ｓｙｋ 또는 ＪＡＫ 키나제 억제제로서의 ２,６－디아미노-피리미딘－５－일－카르복스아미드 |
| US20110071158A1 (en) | 2009-03-18 | 2011-03-24 | Boehringer Ingelheim International Gmbh | New compounds |
| TW201040162A (en) * | 2009-05-06 | 2010-11-16 | Portola Pharm Inc | Inhibitors of JAK |
| CN102458402B (zh) * | 2009-06-12 | 2013-10-02 | 百时美施贵宝公司 | 用作激酶调节剂的烟酰胺化合物 |
| WO2011065800A2 (ko) * | 2009-11-30 | 2011-06-03 | 주식회사 오스코텍 | 피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물 |
| CN111471021B (zh) * | 2011-04-22 | 2024-04-02 | 西格诺药品有限公司 | 取代的二氨基甲酰胺和二氨基甲腈嘧啶，其组合物，和用其治疗的方法 |
| BR112015010244A8 (pt) | 2012-11-08 | 2019-10-01 | Bristol Myers Squibb Co | compostos de piridila substituída por alquil-amida úteis como moduladores de il-12, il-23 e/ou respostas de ifnalfa, sua composição farmacêutica e seu uso |
| UY35126A (es) | 2012-11-08 | 2014-05-30 | Bristol Myers Squibb Co | Ojo es alfa |
| AR094537A1 (es) | 2013-11-07 | 2015-08-12 | Bristol Myers Squibb Co | COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa |
-
2013
- 2013-11-07 MX MX2015005561A patent/MX2015005561A/es unknown
- 2013-11-07 BR BR112015009798A patent/BR112015009798A2/pt not_active Application Discontinuation
- 2013-11-07 SG SG11201503395TA patent/SG11201503395TA/en unknown
- 2013-11-07 WO PCT/US2013/068866 patent/WO2014074670A1/en not_active Ceased
- 2013-11-07 US US14/441,213 patent/US9540333B2/en active Active
- 2013-11-07 EA EA201590911A patent/EA028052B1/ru not_active IP Right Cessation
- 2013-11-07 CA CA2890935A patent/CA2890935A1/en not_active Abandoned
- 2013-11-07 KR KR1020157011660A patent/KR102205914B1/ko active Active
- 2013-11-07 CN CN201380069688.2A patent/CN104903301B/zh active Active
- 2013-11-07 AU AU2013341195A patent/AU2013341195B2/en not_active Ceased
- 2013-11-07 ES ES13795913.6T patent/ES2648226T3/es active Active
- 2013-11-07 EP EP13795913.6A patent/EP2917186B1/en active Active
- 2013-11-07 JP JP2015541885A patent/JP6266639B2/ja active Active
-
2015
- 2015-05-04 IL IL238605A patent/IL238605A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL238605A0 (en) | 2015-06-30 |
| CA2890935A1 (en) | 2014-05-15 |
| SG11201503395TA (en) | 2015-05-28 |
| JP6266639B2 (ja) | 2018-01-24 |
| EA028052B1 (ru) | 2017-10-31 |
| AU2013341195B2 (en) | 2017-09-21 |
| JP2016501185A (ja) | 2016-01-18 |
| MX2015005561A (es) | 2015-07-23 |
| BR112015009798A2 (pt) | 2017-07-11 |
| US20150299139A1 (en) | 2015-10-22 |
| EP2917186A1 (en) | 2015-09-16 |
| CN104903301A (zh) | 2015-09-09 |
| AU2013341195A1 (en) | 2015-07-02 |
| ES2648226T3 (es) | 2017-12-29 |
| WO2014074670A1 (en) | 2014-05-15 |
| KR102205914B1 (ko) | 2021-01-20 |
| EA201590911A1 (ru) | 2015-10-30 |
| US9540333B2 (en) | 2017-01-10 |
| EP2917186B1 (en) | 2017-10-18 |
| CN104903301B (zh) | 2017-08-29 |
| KR20150079678A (ko) | 2015-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL238605A (en) | Converted pyrimidine compounds with alkylamide for use in modulation il-23, il-12, and / or ifnα | |
| HUS2300025I1 (hu) | Amidszubsztituált heterociklikus vegyületek mint IL-12, IL-23 és/vagy IFN-ALFA modulátorai | |
| IL238554A0 (en) | Alkyl-amide substituted pyridyl compounds are useful as modulators of il12, il23, and/or ifnα responses | |
| IL253950B (en) | Cyclic-converted uracils and their use | |
| EP3046932A4 (en) | Evolved sortases and uses thereof | |
| IL235216A0 (en) | Aqueous and lyophilized formulations of antibody against cd40 | |
| HUE036038T2 (hu) | Felület-oxidált alacsony fajlagos felületû grafit, eljárás annak elõállítására, és annak alkalmazása | |
| EP3083606A4 (en) | Pyrimidines and use thereof | |
| EP2815523A4 (en) | RADIO CHANNEL DATA AND THEIR USE | |
| IL241823B (en) | Preparations containing novyi .c and their uses for the treatment of cancerous tumors | |
| EP3046417A4 (en) | METHOD OF USING ADIPOSE TISSUE DERIVED CELLS IN THE MODULATION OF PAIN AND / OR FIBROSIS | |
| GB201309178D0 (en) | Enzyme and uses thereof | |
| EP2855704A4 (en) | NUCLEIC ACID AMPLIFICATION AND USE THEREOF | |
| EP3036849A4 (en) | Bs and ue, and methods used in the same | |
| AU2013902966A0 (en) | Improvements in shoes and the like | |
| ZA201205434B (en) | Coffins, sarcophagi, cinerary urns and the like |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |